In the RYGB sub-cohort, a moderate predictive power of basal chemerin for less improvement of hepatic fibrosis—indicated by NFS and FIB4 index—was detected which was absent among LCD patients. Here, RARRES2 is linked to lattice corneal dystrophy type I.